We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer

This study has been terminated.
(Terminated due to inadequate rate of accrual.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01202890
First Posted: September 16, 2010
Last Update Posted: January 8, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2012
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)